Pfizer Inc. (PFE): price to earnings, 10 filed years
P/E at Pfizer Inc. was 18.31x in FY2025, the newest filed year. Across the 10 computed years from FY2016 it ranged from 9.37x (FY2022) to 77.81x (FY2023), with a median of 18.56x.
Tonight's figure on the company page: 21.49x, at the close of 2026-10-15, recomputed 2026-10-15. The table is each filed year on its own terms, with the formula below; the current figure may use trailing twelve months or, where the explainer says so, a different denominator.
Year by year
| Fiscal year | P/E | Read from |
|---|---|---|
| FY2016 | 27.74x | 10-K, filed 2017-02-23 |
| FY2017 | 10.28x | 10-K, filed 2018-02-22 |
| FY2018 | 22.13x | 10-K, filed 2019-02-28 |
| FY2019 | 13.17x | 10-K, filed 2020-02-27 |
| FY2020 | 22.58x | 10-K, filed 2021-02-25 |
| FY2021 | 15.34x | 10-K, filed 2022-02-24 |
| FY2022 | 9.37x | 10-K, filed 2023-02-23 |
| FY2023 | 77.81x | 10-K, filed 2024-02-22 |
| FY2024 | 18.82x | 10-K, filed 2025-02-27 |
| FY2025 | 18.31x | 10-K, filed 2026-02-26 |
How each year is computed
Close at fiscal year end / diluted earnings per share
P/E, free cash flow yield and EV to EBIT set each filed year against the close on or within a week before that fiscal year's end. The price archive here is about five years deep, so older years of those three read n/a. Per-share figures and share counts are put on today's share count after a confirmed split, the basis the price archive is kept on.
Read further
A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.